Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Age- and disease-related cerebral white matter changes in patients with Parkinson's disease.

de Schipper LJ, Hafkemeijer A, Bouts MJRJ, van der Grond J, Marinus J, Henselmans JML, van Hilten JJ.

Neurobiol Aging. 2019 May 13;80:203-209. doi: 10.1016/j.neurobiolaging.2019.05.004. [Epub ahead of print]

PMID:
31207552
2.

A multimodal MRI-based classification signature emerges just prior to symptom onset in frontotemporal dementia mutation carriers.

Feis RA, Bouts MJRJ, de Vos F, Schouten TM, Panman JL, Jiskoot LC, Dopper EGP, van der Grond J, van Swieten JC, Rombouts SARB.

J Neurol Neurosurg Psychiatry. 2019 Jun 15. pii: jnnp-2019-320774. doi: 10.1136/jnnp-2019-320774. [Epub ahead of print]

PMID:
31203211
3.

Big Data Approaches to Phenotyping Acute Ischemic Stroke Using Automated Lesion Segmentation of Multi-Center Magnetic Resonance Imaging Data.

Wu O, Winzeck S, Giese AK, Hancock BL, Etherton MR, Bouts MJRJ, Donahue K, Schirmer MD, Irie RE, Mocking SJT, McIntosh EC, Bezerra R, Kamnitsas K, Frid P, Wasselius J, Cole JW, Xu H, Holmegaard L, Jiménez-Conde J, Lemmens R, Lorentzen E, McArdle PF, Meschia JF, Roquer J, Rundek T, Sacco RL, Schmidt R, Sharma P, Slowik A, Stanne TM, Thijs V, Vagal A, Woo D, Bevan S, Kittner SJ, Mitchell BD, Rosand J, Worrall BB, Jern C, Lindgren AG, Maguire J, Rost NS; MRI-GENIE and GISCOME Investigators.

Stroke. 2019 Jun 10:STROKEAHA119025373. doi: 10.1161/STROKEAHA.119.025373. [Epub ahead of print]

PMID:
31177973
4.

Ensemble of Convolutional Neural Networks Improves Automated Segmentation of Acute Ischemic Lesions Using Multiparametric Diffusion-Weighted MRI.

Winzeck S, Mocking SJT, Bezerra R, Bouts MJRJ, McIntosh EC, Diwan I, Garg P, Chutinet A, Kimberly WT, Copen WA, Schaefer PW, Ay H, Singhal AB, Kamnitsas K, Glocker B, Sorensen AG, Wu O.

AJNR Am J Neuroradiol. 2019 Jun;40(6):938-945. doi: 10.3174/ajnr.A6077. Epub 2019 May 30.

PMID:
31147354
5.

Single-subject classification of presymptomatic frontotemporal dementia mutation carriers using multimodal MRI.

Feis RA, Bouts MJRJ, Panman JL, Jiskoot LC, Dopper EGP, Schouten TM, de Vos F, van der Grond J, van Swieten JC, Rombouts SARB.

Neuroimage Clin. 2019;22:101718. doi: 10.1016/j.nicl.2019.101718. Epub 2019 Mar 1.

6.

Detection of mild cognitive impairment in a community-dwelling population using quantitative, multiparametric MRI-based classification.

Bouts MJRJ, van der Grond J, Vernooij MW, Koini M, Schouten TM, de Vos F, Feis RA, Cremers LGM, Lechner A, Schmidt R, de Rooij M, Niessen WJ, Ikram MA, Rombouts SARB.

Hum Brain Mapp. 2019 Jun 15;40(9):2711-2722. doi: 10.1002/hbm.24554. Epub 2019 Feb 25.

7.

Multiple Approaches to Diffusion Magnetic Resonance Imaging in Hereditary Cerebral Amyloid Angiopathy Mutation Carriers.

Schouten TM, de Vos F, van Rooden S, Bouts MJRJ, van Opstal AM, Feis RA, Terwindt GM, Wermer MJH, van Buchem MA, Greenberg SM, de Rooij M, Rombouts SARB, van der Grond J.

J Am Heart Assoc. 2019 Feb 5;8(3):e011288. doi: 10.1161/JAHA.118.011288.

8.

Gray and white matter changes in presymptomatic genetic frontotemporal dementia: a longitudinal MRI study.

Panman JL, Jiskoot LC, Bouts MJRJ, Meeter LHH, van der Ende EL, Poos JM, Feis RA, Kievit AJA, van Minkelen R, Dopper EGP, Rombouts SARB, van Swieten JC, Papma JM.

Neurobiol Aging. 2019 Apr;76:115-124. doi: 10.1016/j.neurobiolaging.2018.12.017. Epub 2019 Jan 7.

9.

Single-subject classification of presymptomatic frontotemporal dementia mutation carriers using multimodal MRI.

Feis RA, Bouts MJRJ, Panman JL, Jiskoot LC, Dopper EGP, Schouten TM, de Vos F, van der Grond J, van Swieten JC, Rombouts SARB.

Neuroimage Clin. 2018 Jul 17;20:188-196. doi: 10.1016/j.nicl.2018.07.014. eCollection 2018. Erratum in: Neuroimage Clin. 2019;22:101718.

10.

Single Subject Classification of Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia Using Anatomical, Diffusion Tensor, and Resting-State Functional Magnetic Resonance Imaging.

Bouts MJRJ, Möller C, Hafkemeijer A, van Swieten JC, Dopper E, van der Flier WM, Vrenken H, Wink AM, Pijnenburg YAL, Scheltens P, Barkhof F, Schouten TM, de Vos F, Feis RA, van der Grond J, de Rooij M, Rombouts SARB.

J Alzheimers Dis. 2018;62(4):1827-1839. doi: 10.3233/JAD-170893.

PMID:
29614652
11.

Design and rationale for examining neuroimaging genetics in ischemic stroke: The MRI-GENIE study.

Giese AK, Schirmer MD, Donahue KL, Cloonan L, Irie R, Winzeck S, Bouts MJRJ, McIntosh EC, Mocking SJ, Dalca AV, Sridharan R, Xu H, Frid P, Giralt-Steinhauer E, Holmegaard L, Roquer J, Wasselius J, Cole JW, McArdle PF, Broderick JP, Jimenez-Conde J, Jern C, Kissela BM, Kleindorfer DO, Lemmens R, Lindgren A, Meschia JF, Rundek T, Sacco RL, Schmidt R, Sharma P, Slowik A, Thijs V, Woo D, Worrall BB, Kittner SJ, Mitchell BD, Rosand J, Golland P, Wu O, Rost NS.

Neurol Genet. 2017 Aug 24;3(5):e180. doi: 10.1212/NXG.0000000000000180. eCollection 2017 Oct.

12.

Diffuse microvascular dysfunction and loss of white matter integrity predict poor outcomes in patients with acute ischemic stroke.

Rost NS, Cougo P, Lorenzano S, Li H, Cloonan L, Bouts MJ, Lauer A, Etherton MR, Karadeli HH, Musolino PL, Copen WA, Arai K, Lo EH, Feske SK, Furie KL, Wu O.

J Cereb Blood Flow Metab. 2018 Jan;38(1):75-86. doi: 10.1177/0271678X17706449. Epub 2017 May 8.

13.

Prediction of hemorrhagic transformation after experimental ischemic stroke using MRI-based algorithms.

Bouts MJ, Tiebosch IA, Rudrapatna US, van der Toorn A, Wu O, Dijkhuizen RM.

J Cereb Blood Flow Metab. 2017 Aug;37(8):3065-3076. doi: 10.1177/0271678X16683692. Epub 2016 Jan 1.

14.

Magnetic resonance imaging of local and remote vascular remodelling after experimental stroke.

Yanev P, Seevinck PR, Rudrapatna US, Bouts MJ, van der Toorn A, Gertz K, Kronenberg G, Endres M, van Tilborg GA, Dijkhuizen RM.

J Cereb Blood Flow Metab. 2017 Aug;37(8):2768-2779. doi: 10.1177/0271678X16674737. Epub 2016 Jan 1.

15.

Magnetic resonance imaging-based cerebral tissue classification reveals distinct spatiotemporal patterns of changes after stroke in non-human primates.

Bouts MJ, Westmoreland SV, de Crespigny AJ, Liu Y, Vangel M, Dijkhuizen RM, Wu O, D'Arceuil HE.

BMC Neurosci. 2015 Dec 15;16:91. doi: 10.1186/s12868-015-0226-7.

16.

Role of Acute Lesion Topography in Initial Ischemic Stroke Severity and Long-Term Functional Outcomes.

Wu O, Cloonan L, Mocking SJ, Bouts MJ, Copen WA, Cougo-Pinto PT, Fitzpatrick K, Kanakis A, Schaefer PW, Rosand J, Furie KL, Rost NS.

Stroke. 2015 Sep;46(9):2438-44. doi: 10.1161/STROKEAHA.115.009643. Epub 2015 Jul 21.

17.

Lesion development and reperfusion benefit in relation to vascular occlusion patterns after embolic stroke in rats.

Bouts MJ, Tiebosch IA, van der Toorn A, Hendrikse J, Dijkhuizen RM.

J Cereb Blood Flow Metab. 2014 Feb;34(2):332-8. doi: 10.1038/jcbfm.2013.202. Epub 2013 Dec 4.

18.

Comparing tolerability and efficacy of generic versus brand alendronate: a randomized clinical study in postmenopausal women with a recent fracture.

van den Bergh JP, Bouts ME, van der Veer E, van der Velde RY, Janssen MJ, Geusens PP, Winkens B, Oldenhof NJ, van Geel TA.

PLoS One. 2013 Oct 21;8(10):e78153. doi: 10.1371/journal.pone.0078153. eCollection 2013.

19.

Progression of brain lesions in relation to hyperperfusion from subacute to chronic stages after experimental subarachnoid hemorrhage: a multiparametric MRI study.

Tiebosch IA, van den Bergh WM, Bouts MJ, Zwartbol R, van der Toorn A, Dijkhuizen RM.

Cerebrovasc Dis. 2013;36(3):167-72. doi: 10.1159/000352048. Epub 2013 Oct 12.

PMID:
24135525
20.

Early identification of potentially salvageable tissue with MRI-based predictive algorithms after experimental ischemic stroke.

Bouts MJ, Tiebosch IA, van der Toorn A, Viergever MA, Wu O, Dijkhuizen RM.

J Cereb Blood Flow Metab. 2013 Jul;33(7):1075-82. doi: 10.1038/jcbfm.2013.51. Epub 2013 Apr 10.

21.

Combined treatment with recombinant tissue plasminogen activator and dexamethasone phosphate-containing liposomes improves neurological outcome and restricts lesion progression after embolic stroke in rats.

Tiebosch IA, Crielaard BJ, Bouts MJ, Zwartbol R, Salas-Perdomo A, Lammers T, Planas AM, Storm G, Dijkhuizen RM.

J Neurochem. 2012 Nov;123 Suppl 2:65-74. doi: 10.1111/j.1471-4159.2012.07945.x.

22.

Effect of interferon-β on neuroinflammation, brain injury and neurological outcome after experimental subarachnoid hemorrhage.

Tiebosch IA, Dijkhuizen RM, Cobelens PM, Bouts MJ, Zwartbol R, van der Meide PH, van den Bergh WM.

Neurocrit Care. 2013 Feb;18(1):96-105. doi: 10.1007/s12028-012-9692-2.

PMID:
22434548
23.

Manganese-enhanced MRI of brain plasticity in relation to functional recovery after experimental stroke.

van der Zijden JP, Bouts MJ, Wu O, Roeling TA, Bleys RL, van der Toorn A, Dijkhuizen RM.

J Cereb Blood Flow Metab. 2008 Apr;28(4):832-40. Epub 2007 Nov 7.

PMID:
17987047
24.

Hydrocortisone-induced increase of PDGF beta-receptor expression in a human malignant mesothelioma cell line.

Versnel MA, Bouts MJ, Langerak AW, van der Kwast TH, Hoogsteden HC, Hagemeijer A, Heldin CH.

Exp Cell Res. 1992 May;200(1):83-8.

PMID:
1314190
25.

Human malignant mesothelioma cell lines express PDGF beta-receptors whereas cultured normal mesothelial cells express predominantly PDGF alpha-receptors.

Versnel MA, Claesson-Welsh L, Hammacher A, Bouts MJ, van der Kwast TH, Eriksson A, Willemsen R, Weima SM, Hoogsteden HC, Hagemeijer A, et al.

Oncogene. 1991 Nov;6(11):2005-11.

PMID:
1658707
26.

Cytogenetic analysis of malignant mesothelioma.

Hagemeijer A, Versnel MA, Van Drunen E, Moret M, Bouts MJ, van der Kwast TH, Hoogsteden HC.

Cancer Genet Cytogenet. 1990 Jul 1;47(1):1-28.

PMID:
2357680
27.

Characterization of three human malignant mesothelioma cell lines.

Versnel MA, Hoogsteden HC, Hagemeijer A, Bouts MJ, van der Kwast TH, Delahaye M, Schaart G, Ramaekers FC.

Cancer Genet Cytogenet. 1989 Oct 1;42(1):115-28.

PMID:
2790740
28.

Establishment of human malignant mesothelioma cell lines.

Versnel MA, Bouts MJ, Hoogsteden HC, van der Kwast TH, Delahaye M, Hagemeijer A.

Int J Cancer. 1989 Aug 15;44(2):256-60.

PMID:
2474517
29.

Expression of c-sis (PDGF B-chain) and PDGF A-chain genes in ten human malignant mesothelioma cell lines derived from primary and metastatic tumors.

Versnel MA, Hagemeijer A, Bouts MJ, van der Kwast TH, Hoogsteden HC.

Oncogene. 1988 Jun;2(6):601-5.

PMID:
3290807

Supplemental Content

Support Center